Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
advancedbiotech.com

See what CB Insights has to offer

Founded Year

1995

Stage

Acquired | Acquired

About Advanced Bio-Technologies

Advanced Bio-Technologies was a Healthcare/Pharmaceuticals / Drugs company based in Clearwater, Florida. Advanced Bio-Technologies was acquired in 2007.

Advanced Bio-Technologies Headquarter Location

14010 Roosevelt Boulevard Suite 706

Clearwater, Florida, 33762,

United States

727-533-8400

Latest Advanced Bio-Technologies News

Small Talk: Sinclair boosts portfolio with £21m Advanced Bio-Technologies deal

Dec 12, 2011

Nikhil Kumar Monday 12 December 2011 00:00 BST Sinclair Pharma and IS Pharma agreed to merge in April, with shares in the combined business (imaginatively christened Sinclair IS Pharma) starting trading in late May. Since then, the stock has been under pressure, easing as volatility in the wider market gathered pace. But the share price received a shot in the arm last week, after the company, which specialises in dermatological and wound care treatments, unveiled plans to buy the privately held US biotech company, Advanced Bio-Technologies (ABT). The £21m cash and share deal, which has been structured to exclude ABT's US business, will boost Sinclair's suite of skincare products. The main offering is its Kelo-cote scar treatment, which will become Sinclair's second largest brand after Flammazine. Sinclair gets ownership of the flagship (and high margin) product in all markets outside the US. Since it wasalready licensed for Kelo-cote in its core European markets, the deal opens up fast growing countries such as Brazil, Korea and China. In all, ABT's international business delivered revenues of $6.1m last year. That works out to growth of 19 per cent on the year before. And things are looking up. "Based on the results in the first ten months of the current financial year to [the end of October], ABT's international revenues are expected to grow by approximately 40 per cent by the end of 2011, including revenues from Sinclair IS in Europe," the company said when it unveiled the deal on 8 December. Looking more closely at Kelo-cote, Sinclair said the treatment already has a foothold in Brazil, with the country, which will serve as a springboard for expansion into other Latin American markets, generating around $2m in revenues. On the other side of the world, in Asia, Kelo-cote boasts $1.1m in revenues in South Korea. It is also sold in other countries in the region, including China. It's also worth noting that ABT has been pushing the treatment quite strongly in terms of marketing. This means that while Sinclair is looking to bolster the efforts, it will only need two additional staff to fulfil its ambitions in that regard. The reaction in the markets was certainly positive, with the stock up 10 per cent since the announcement. The City was also welcoming. Pointing to Kelo-cote, Finncap analysts said the deal was essentially an "asset purchase". "We estimate that the incremental Kelo-cote revenues in the year ending June 2013 will be of the order of $8m," they said. "This is a high gross margin product (we estimate more than 70 per cent) and the incremental costs (sales, marketing and shipping) we estimate will be about $1m... the net contribution to the bottom line will of the order of $4m. " Their counterparts at Singer Capital Markets added that the deal, which comes after Sinclair sold off its Mysoline epilepsy treatment, fitted with the company's strategy of focusing on its core areas. "We note that the company has successfully recycled income from the divestment of Mysoline (a less attractive portfolio product) in order to fund this acquisition," Singer said. More about:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Advanced Bio-Technologies Patents

Advanced Bio-Technologies has filed 21 patents.

The 3 most popular patent topics include:

  • Animation techniques
  • Body piercing
  • Cephalopod zootomy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/12/2014

6/29/2021

Mechanics, Fiber optics, Aerodynamics, Optical fiber, Quantum mechanics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/12/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/29/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Mechanics, Fiber optics, Aerodynamics, Optical fiber, Quantum mechanics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.